KVUE

Kenvue Inc. NYSE

Consumer Defensive ·Household & Personal Products ·US · kenvue.com

$17.43

Mkt Cap $33.5B

52w Low $14.02 30.6% of range 52w High $25.17

50d MA $17.78 200d MA $17.98

P/E (TTM) 22.6x

EV/EBITDA 13.8x

P/B 3.1x

Debt/Equity 0.8x

ROE 13.7%

P/FCF 19.1x

RSI (14) —

ATR (14) —

Beta 0.57

50d MA $17.78

200d MA $17.98

Avg Volume 31.8M

About

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hai…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 17, 2026	AMC	0.22	0.27	+21.2%	18.41	+0.7%	+2.6%	+1.4%	+1.7%	+2.9%	+3.3%	-5.3%	—
Nov 3, 2025	AMC	0.26	0.28	+7.6%	16.14	-0.1%	-1.1%	+0.6%	+2.0%	+4.6%	+3.9%	+5.1%	—
Aug 7, 2025	AMC	0.28	0.29	+2.9%	21.76	-0.6%	-1.9%	-2.5%	+0.6%	-0.2%	-3.2%	-15.3%	—
May 8, 2025	AMC	0.23	0.24	+5.5%	24.06	-0.0%	+1.6%	-0.2%	-1.7%	-3.6%	-0.7%	-11.5%	—
Feb 6, 2025	AMC	0.26	0.26	+0.0%	19.80	+0.5%	+1.9%	+3.9%	+5.6%	+5.9%	+8.3%	+20.8%	—
Nov 7, 2024	AMC	0.27	0.28	+2.8%	22.97	-0.4%	+3.1%	+3.5%	+3.0%	+0.7%	+2.8%	-0.7%	—
Aug 6, 2024	AMC	0.28	0.32	+16.1%	20.86	-0.8%	-1.2%	+1.9%	+0.8%	+1.1%	+2.3%	+7.9%	—
May 7, 2024	AMC	0.25	0.28	+10.2%	20.08	+0.0%	+1.8%	+2.3%	+2.3%	+1.4%	+2.7%	-7.2%	—
Feb 8, 2024	AMC	0.28	0.31	+9.5%	19.33	-0.7%	+0.0%	+1.3%	-0.4%	-1.2%	-1.4%	+4.2%	—
Oct 26, 2023	AMC	0.30	0.31	+3.3%	18.69	-0.4%	-2.6%	-0.3%	-0.5%	+1.0%	+2.9%	+7.9%	—
Jul 20, 2023	AMC	0.29	0.32	+10.3%	24.51	+0.6%	-2.0%	-1.4%	+2.5%	+0.7%	-1.1%	-6.6%	—
Jun 2, 2023	AMC	0.32	0.19	-40.6%	25.55	+0.1%	-1.6%	-1.5%	-1.8%	-1.7%	-1.8%	+1.9%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 15	Citigroup	Maintains	Neutral → Neutral	—	$17.38	$17.35	-0.2%	-0.5%	+0.5%	+1.3%	+1.2%	-0.5%
Apr 14	Barclays	Maintains	Equal Weight → Equal Weight	—	$17.26	$17.18	-0.5%	+0.7%	+0.2%	+1.2%	+2.0%	+1.9%
Apr 7	UBS	Maintains	Neutral → Neutral	—	$17.30	$17.25	-0.3%	-3.3%	+0.2%	+0.8%	+0.3%	-0.2%
Mar 6	Barclays	Maintains	Equal Weight → Equal Weight	—	$18.25	$18.09	-0.9%	+0.8%	-0.5%	-1.6%	-3.3%	-4.7%
Feb 18	UBS	Maintains	Neutral → Neutral	—	$18.41	$18.54	+0.7%	+2.6%	+1.4%	+1.7%	+2.9%	+3.3%
Feb 18	Citigroup	Maintains	Neutral → Neutral	—	$18.41	$18.54	+0.7%	+2.6%	+1.4%	+1.7%	+2.9%	+3.3%
Feb 18	Canaccord Genuity	Maintains	Hold → Hold	—	$18.41	$18.54	+0.7%	+2.6%	+1.4%	+1.7%	+2.9%	+3.3%
Jan 30	Jefferies	Downgrade	Buy → Hold	—	$17.20	$17.19	-0.1%	+1.2%	+1.0%	+2.3%	+4.7%	+5.1%
Nov 10	Barclays	Maintains	Equal Weight → Equal Weight	—	$16.88	$16.74	-0.8%	-0.7%	-0.9%	-1.2%	-0.7%	-1.3%
Oct 29	Canaccord Genuity	Downgrade	Buy → Hold	—	$14.51	$14.34	-1.2%	-1.4%	-1.9%	-1.0%	+11.2%	+10.1%
Oct 27	Jefferies	Maintains	Buy → Buy	—	$15.00	$15.10	+0.7%	+0.5%	-3.3%	-4.6%	-5.1%	-4.2%
Oct 10	JP Morgan	Maintains	Overweight → Overweight	—	$16.84	$16.85	+0.1%	-1.1%	-3.7%	-4.1%	-3.4%	-16.2%
Oct 9	Citigroup	Maintains	Neutral → Neutral	—	$16.08	$16.17	+0.6%	+4.7%	+3.5%	+0.9%	+0.4%	+1.1%
Oct 8	BofA Securities	Maintains	Buy → Buy	—	$16.22	$16.10	-0.7%	-0.9%	+3.8%	+2.7%	+0.0%	-0.4%
Oct 8	UBS	Maintains	Neutral → Neutral	—	$16.22	$16.10	-0.7%	-0.9%	+3.8%	+2.7%	+0.0%	-0.4%
Oct 2	Goldman Sachs	Maintains	Neutral → Neutral	—	$15.85	$15.92	+0.4%	-0.8%	-0.3%	-1.0%	+2.3%	+1.5%
Oct 1	Barclays	Maintains	Equal Weight → Equal Weight	—	$16.23	$16.22	-0.1%	-2.3%	-3.1%	-2.6%	-3.3%	-0.1%
Sep 26	Rothschild & Co	Upgrade	Neutral → Buy	—	$16.17	$16.42	+1.5%	+1.5%	+1.1%	+0.4%	-2.0%	-2.7%
Sep 23	Evercore ISI	Maintains	In Line → In Line	—	$16.97	$17.90	+5.5%	+1.6%	-0.6%	-4.7%	-3.2%	-3.7%
Sep 16	Citigroup	Maintains	Neutral → Neutral	—	$18.25	$18.35	+0.5%	-0.7%	+0.5%	-0.8%	+0.5%	-7.0%
Sep 8	Evercore ISI	Maintains	In Line → In Line	—	$18.62	$18.75	+0.7%	-1.0%	+1.3%	-0.8%	+1.2%	+2.0%
Aug 8	Canaccord Genuity	Maintains	Buy → Buy	—	$21.76	$21.62	-0.6%	-1.9%	-2.5%	+0.6%	-0.2%	-3.2%
Aug 8	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$21.76	$21.62	-0.6%	-1.9%	-2.5%	+0.6%	-0.2%	-3.2%
Jul 25	JP Morgan	Maintains	Overweight → Overweight	—	$22.50	$22.46	-0.2%	+1.5%	-0.6%	-1.5%	-3.6%	-4.7%
Jul 17	UBS	Maintains	Neutral → Neutral	—	$21.85	$21.83	-0.1%	+0.0%	+0.7%	+1.3%	+3.8%	+3.2%
Jul 15	Citigroup	Maintains	Neutral → Neutral	—	$21.82	$21.58	-1.1%	-2.0%	+0.1%	+0.1%	+0.8%	+1.4%
Jul 15	BofA Securities	Maintains	Buy → Buy	—	$21.82	$21.58	-1.1%	-2.0%	+0.1%	+0.1%	+0.8%	+1.4%
Jul 15	Barclays	Maintains	Equal Weight → Equal Weight	—	$21.82	$21.58	-1.1%	-2.0%	+0.1%	+0.1%	+0.8%	+1.4%
May 12	Barclays	Maintains	Equal Weight → Equal Weight	—	$24.44	$24.26	-0.7%	-1.8%	-3.2%	-5.1%	-2.3%	-1.1%
May 9	UBS	Maintains	Neutral → Neutral	—	$24.06	$24.05	-0.0%	+1.6%	-0.2%	-1.7%	-3.6%	-0.7%
May 9	Citigroup	Maintains	Neutral → Neutral	—	$24.06	$24.05	-0.0%	+1.6%	-0.2%	-1.7%	-3.6%	-0.7%
Apr 14	Barclays	Maintains	Equal Weight → Equal Weight	—	$22.09	$22.37	+1.3%	+2.8%	+3.7%	+2.9%	+5.9%	+0.8%
Apr 14	Citigroup	Maintains	Neutral → Neutral	—	$22.09	$22.37	+1.3%	+2.8%	+3.7%	+2.9%	+5.9%	+0.8%
Mar 27	Barclays	Maintains	Equal Weight → Equal Weight	—	$23.40	$23.46	+0.3%	+0.4%	+1.3%	+2.5%	+2.1%	+2.0%
Mar 5	Canaccord Genuity	Maintains	Buy → Buy	—	$23.42	$23.43	+0.0%	-1.6%	-1.0%	+0.0%	+2.1%	+0.3%
Feb 24	Piper Sandler	Maintains	Overweight → Overweight	—	$23.32	$23.30	-0.1%	-0.1%	+0.2%	-0.4%	-0.8%	+1.2%
Feb 7	UBS	Maintains	Neutral → Neutral	—	$19.80	$19.90	+0.5%	+1.9%	+3.9%	+5.6%	+5.9%	+8.3%
Feb 7	Canaccord Genuity	Maintains	Buy → Buy	—	$19.80	$19.90	+0.5%	+1.9%	+3.9%	+5.6%	+5.9%	+8.3%
Feb 3	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$21.29	$21.18	-0.5%	-0.3%	-2.3%	-2.6%	-7.0%	-5.2%
Jan 17	Barclays	Maintains	Equal Weight → Equal Weight	—	$21.19	$21.20	+0.0%	-0.4%	-1.8%	-2.1%	-2.1%	-1.9%
Jan 16	UBS	Maintains	Neutral → Neutral	—	$20.85	$20.74	-0.5%	+1.6%	+1.2%	-0.2%	-0.5%	-0.5%
Jan 15	Citigroup	Maintains	Neutral → Neutral	—	$21.03	$21.19	+0.8%	-0.9%	+0.8%	+0.3%	-1.1%	-1.3%
Jan 6	Piper Sandler	Upgrade	Neutral → Overweight	—	$21.20	$21.60	+1.9%	-0.4%	-0.7%	-0.5%	-1.7%	-1.1%
Dec 12	Deutsche Bank	Downgrade	Buy → Hold	—	$22.22	$21.98	-1.1%	+0.5%	-0.0%	-0.7%	-0.8%	-3.2%
Oct 22	BofA Securities	Maintains	Buy → Buy	—	$22.92	$22.55	-1.6%	+0.0%	-0.7%	+0.2%	-1.2%	-0.2%
Oct 11	JP Morgan	Maintains	Overweight → Overweight	—	$21.32	$21.39	+0.3%	+0.7%	+1.3%	+2.1%	+1.9%	+0.6%
Sep 24	RBC Capital	Downgrade	Outperform → Sector Perform	—	$23.02	$23.03	+0.0%	+0.4%	-0.1%	+0.5%	+1.0%	+0.5%
Sep 23	Piper Sandler	Maintains	Neutral → Neutral	—	$23.02	$22.83	-0.8%	+0.0%	+0.4%	-0.1%	+0.5%	+1.0%
Aug 7	Deutsche Bank	Maintains	Buy → Buy	—	$20.86	$20.69	-0.8%	-1.2%	+1.9%	+0.8%	+1.1%	+2.3%
Aug 7	JP Morgan	Maintains	Overweight → Overweight	—	$20.86	$20.69	-0.8%	-1.2%	+1.9%	+0.8%	+1.1%	+2.3%

Recent Filings

8-K · 5.02 !!! Very High

Unknown — 8-K 5.02: Executive Change

KVUE promoted an internal executive to interim CFO with a $125,000 monthly stipend, signaling either financial instability or a planned succession that investors should monitor for permanent leadership clarity.

Apr 15

8-K

Kenvue Inc. -- 8-K Filing

Kenvue's restructuring cost estimates carry significant uncertainty due to varying jurisdictional requirements, potentially creating financial volatility for investors depending on actual implementation expenses.

Feb 17

8-K · 5.02 !!! Very High

Kenvue Inc. -- 8-K 5.02: Executive Change

Kenvue appointed Amit Banati as principal financial officer while he simultaneously resigned as CFO, indicating a potential transition or restructuring of the finance leadership role.

Feb 12

Data updated apr 25, 2026 6:13pm · Source: massive.com